Published in J Neurol on July 01, 2002
An RCT of a Patient-initiated Treatment Service for BEB and HFS | NCT02577224
The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. Brain (2011) 1.44
Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry (2004) 1.22
Blepharospasm and the modulation of cortical excitability in primary and secondary motor areas. Neurology (2009) 1.18
FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. Ophthalmology (2009) 0.97
Nonmotor manifestations of dystonia: a systematic review. Mov Disord (2011) 0.95
Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value. J Neurol (2012) 0.95
An international survey of patients with cervical dystonia. J Neurol (2015) 0.94
Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE). BMC Neurol (2011) 0.91
An open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport). BMJ Open (2013) 0.90
Botulinum toxin therapy for cervical dystonia: the science of dosing. Tremor Other Hyperkinet Mov (N Y) (2014) 0.86
Psychiatric comorbidities in dystonia: emerging concepts. Mov Disord (2013) 0.85
The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J Neurol (2014) 0.85
Transcranial direct current stimulation for patients with benign essential blepharospasm: a case report. Neurol Sci (2016) 0.84
Physical therapy program for cervical dystonia: a study of 20 cases. Funct Neurol (2013) 0.82
Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial. BMC Neurol (2013) 0.80
A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins. Neuropsychiatr Dis Treat (2011) 0.80
Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)". Neurol Sci (2014) 0.80
Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment. Toxins (Basel) (2015) 0.79
Long-term neuropsychiatric outcomes after pallidal stimulation in primary and secondary dystonia. Neurology (2015) 0.79
Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A. Patient Prefer Adherence (2015) 0.77
Psychiatric disorders in idiopathic-isolated focal dystonia. J Neurol (2014) 0.76
Sexual Well-Being in Patients with Blepharospasm, Spasmodic Torticollis, and Hemifacial Spasm: A Pilot Study. Front Psychol (2016) 0.75
A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom. Neuropsychiatr Dis Treat (2015) 0.75
Nonmotor symptoms in primary adult-onset cervical dystonia and blepharospasm. Brain Behav (2016) 0.75
Clinimetric testing of the comprehensive cervical dystonia rating scale. Mov Disord (2016) 0.75
Long-Term Clinical Outcome of Internal Globus Pallidus Deep Brain Stimulation for Dystonia. PLoS One (2016) 0.75
Intractable Blepharospasm Treated with Bilateral Pallidal Deep Brain Stimulation. Tremor Other Hyperkinet Mov (N Y) (2017) 0.75
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci (1999) 5.01
Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science (1998) 3.58
Separation and purification of a potent bactericidal/permeability-increasing protein and a closely associated phospholipase A2 from rabbit polymorphonuclear leukocytes. Observations on their relationship. J Biol Chem (1979) 3.15
Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation (2001) 2.82
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet (2009) 2.76
Long-term mortality after intracerebral hemorrhage. Neurology (2006) 2.71
Repression of cyclin D1: a novel function of MYC. Mol Cell Biol (1994) 2.67
An alternative pathway for gene regulation by Myc. EMBO J (1997) 2.43
Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study) BMJ (1996) 2.42
Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry (2002) 2.36
Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone (2005) 2.30
Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation (1997) 2.18
Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res (1999) 2.17
Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet (1987) 2.13
Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry (1998) 2.13
Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci U S A (1994) 2.09
Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis. EMBO J (2000) 2.05
Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer (1987) 2.03
Human papillomaviruses in women with a history of abnormal Papanicolaou smears and in their male partners. Obstet Gynecol (1987) 1.97
Long-term pharmacokinetics of clozapine. Br J Psychiatry (1998) 1.97
Rational design of peptide antibiotics by targeted replacement of bacterial and fungal domains. Science (1995) 1.94
Assembly of CNS myelin in the absence of proteolipid protein. Neuron (1997) 1.93
Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J Virol (1988) 1.90
Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology (1997) 1.86
Structure of the collagen-binding domain from a Staphylococcus aureus adhesin. Nat Struct Biol (1997) 1.80
European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect (2000) 1.80
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol (1998) 1.80
Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol (2001) 1.79
Distinct localization and cell cycle dependence of COOH terminally tyrosinolated alpha-tubulin in the microtubules of Trypanosoma brucei brucei. J Cell Biol (1987) 1.78
Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology (2005) 1.77
Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol (2001) 1.77
The MONICA Augsburg surveys--basis for prospective cohort studies. Gesundheitswesen (2005) 1.76
Ataxia, delayed dentition and hypomyelination: a novel leukoencephalopathy. Neuropediatrics (2007) 1.75
Juvenile asymmetric segmental spinal muscular atrophy (Hirayama's disease): three cases without evidence of "flexion myelopathy". Acta Neurol Scand (2001) 1.74
Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst (1989) 1.72
Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer (1985) 1.71
Acupuncture compared to placebo-acupuncture for postoperative nausea and vomiting prophylaxis: a randomised placebo-controlled patient and observer blind trial. Anaesthesia (2004) 1.71
Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy (2006) 1.70
Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry (2000) 1.70
What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry (1998) 1.69
Nitrate reductase of green algae is located in the pyrenoid. Plant Physiol (1985) 1.68
First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying. Gut (1998) 1.68
Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology (1992) 1.64
Prenatal deficiency of phosphate, phosphate supplementation, and rickets in very-low-birthweight infants. Lancet (1990) 1.59
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic study. Neurology (1997) 1.58
Improved tumor staging by diagnostic laparoscopy. Z Gastroenterol (1999) 1.58
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. Eur J Neurol (2012) 1.57
Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study. J Neurol Neurosurg Psychiatry (1999) 1.57
Neuropsychological, MRI and EEG findings after very mild traumatic brain injury. Brain Inj (1999) 1.55
Independent association of von Willebrand factor with surrogate markers of atherosclerosis in middle-aged asymptomatic subjects. J Thromb Haemost (2005) 1.55
Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease. Eur Heart J (2001) 1.53
Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A. Neurology (2008) 1.52
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur J Neurol (2013) 1.52
Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol (2001) 1.52
Distal myasthenia gravis frequency and clinical course in a large prospective series. Acta Neurol Scand (2003) 1.50
Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron (1994) 1.50
The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res (2001) 1.50
Increased rectal cell proliferation following alcohol abuse. Gut (2001) 1.49
Slow-transit constipation after radical hysterectomy type III. Surg Endosc (2002) 1.49
Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology (2007) 1.48
Using triazolam to reduce dental anxiety. J Am Dent Assoc (1993) 1.47
Poor response to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease. Circulation (1999) 1.46
Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology (2002) 1.46
Laparoscopic-assisted vaginal versus abdominal surgery in patients with endometrial cancer--a prospective randomized trial. Gynecol Oncol (2001) 1.45
Ataxia without telangiectasia masquerading as benign hereditary chorea. Mov Disord (1996) 1.45
Method of fabricating a hollow obturator. J Prosthet Dent (1978) 1.45
Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective? Clin Pharmacol Ther (2008) 1.45
Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Neurology (2008) 1.45
TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer. Oncogene (1998) 1.45
Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. Neuroscience (2002) 1.42
Subcutaneous apomorphine in Parkinson's disease. Lancet (1988) 1.41
Early botulinum toxin treatment for spastic pes equinovarus--a randomized double-blind placebo-controlled study. Eur J Neurol (2014) 1.41
Value of laparoscopic evaluation of paraaortic and pelvic lymph nodes for treatment of cervical cancer. Am J Obstet Gynecol (1998) 1.40
Clinical and laboratory data in heterozygous factor V Leiden mutation positive versus negative patients with TIA and minor stroke. Stroke (1995) 1.40
An innovative, safe and sterile sigmoid access (ISSA) for NOTES. Endoscopy (2007) 1.39
Transient restless legs syndrome after spinal anesthesia: a prospective study. Neurology (2002) 1.39
[Spinal fibrocartilaginous embolism]. Nervenarzt (2005) 1.39
[Vascular parkinsonian syndrome]. Nervenarzt (2006) 1.39
Cortical and brain stem hyperexcitability in striatonigral degeneration. Mov Disord (1998) 1.38
NOTES for the cardia: antireflux therapy via transluminal access. Endoscopy (2010) 1.38
Osteoarthritis after arthroscopic partial meniscectomy. Am J Sports Med (1995) 1.37
A transgenic rat model of Charcot-Marie-Tooth disease. Neuron (1996) 1.37
In vitro import of proteins into mitochondria of Trypanosoma brucei and Leishmania tarentolae. J Cell Sci (1996) 1.36
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene Ther (2006) 1.35
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol (1997) 1.35
Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest (2001) 1.35
Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research. Eur J Cancer (2006) 1.33
Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res (1993) 1.33